Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4(+) T cells

PIK3CD 的激活突变会破坏人和小鼠 CD4(+) T 细胞的分化和功能。

阅读:2

Abstract

BACKGROUND: Gain-of-function (GOF) mutations in PIK3CD cause a primary immunodeficiency characterized by recurrent respiratory tract infections, susceptibility to herpesvirus infections, and impaired antibody responses. Previous work revealed defects in CD8(+) T and B cells that contribute to this clinical phenotype, but less is understood about the role of CD4(+) T cells in disease pathogenesis. OBJECTIVE: We sought to dissect the effects of increased phosphoinositide 3-kinase (PI3K) signaling on CD4(+) T-cell function. METHODS: We performed detailed ex vivo, in vivo, and in vitro phenotypic and functional analyses of patients' CD4(+) T cells and a novel murine disease model caused by overactive PI3K signaling. RESULTS: PI3K overactivation caused substantial increases in numbers of memory and follicular helper T (T(FH)) cells and dramatic changes in cytokine production in both patients and mice. Furthermore, PIK3CD GOF human T(FH) cells had dysregulated phenotype and function characterized by increased programmed cell death protein 1, CXCR3, and IFN-γ expression, the phenotype of a T(FH) cell subset with impaired B-helper function. This was confirmed in vivo in which Pik3cd GOF CD4(+) T cells also acquired an aberrant T(FH) phenotype and provided poor help to support germinal center reactions and humoral immune responses by antigen-specific wild-type B cells. The increase in numbers of both memory and T(FH) cells was largely CD4(+) T-cell extrinsic, whereas changes in cytokine production and T(FH) cell function were cell intrinsic. CONCLUSION: Our studies reveal that CD4(+) T cells with overactive PI3K have aberrant activation and differentiation, thereby providing mechanistic insight into dysfunctional antibody responses in patients with PIK3CD GOF mutations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。